RecruitingNot ApplicableNCT06366113

Time of Exercise Re-training With Chronic Obstructive Pulmonary Disease (COPD)

Effect of Time of Exercise Re-training on Functional Capacity in Individuals With Chronic Obstructive Pulmonary Disease (COPD)


Sponsor

Michaël RACODON

Enrollment

90 participants

Start Date

Jan 2, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Pulmonary rehabilitation (PR) is an effective intervention for reducing hospital readmissions, secondary events, and mortality in patients with respiratory pathologies. The program should not be improved by introducing new subjects such as circadian rhythm.


Eligibility

Min Age: 18 YearsMax Age: 85 Years

Plain Language Summary

Simplified for easier understanding

This study is comparing the effects of exercising in the morning versus the evening as part of a pulmonary rehabilitation program for people with COPD (chronic obstructive pulmonary disease, a condition that makes breathing difficult). **You may be eligible if...** - You are 18 or older - You have been diagnosed with COPD - You are enrolled in a respiratory rehabilitation program with at least 18 sessions over 4 weeks - You are covered by social security **You may NOT be eligible if...** - You have heart conditions that make exercise unsafe - You have other health conditions that prevent participation in a rehabilitation program - You are unable to provide written informed consent Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERPulmonary rehabilitation

Pulmonary rehabilitation includes : * Exercise re-training with resumption of physical activities * therapeutic patient education


Locations(1)

Clinique la Mitterie

Lille, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06366113


Related Trials